Regulation of cell cycle entry by PTEN in smooth muscle cell proliferation of human coronary artery bypass conduits

Journal of Cellular and Molecular Medicine

Volumn 13, Issue 3, 2009, Pages 547-554

  Jia, Guanghong ^a   Mitra, Amit K ^a   Gangahar, Deepak M ^b   Agrawal, Devendra K ^a  

^a CREIGHTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Nebraska Heart Hospital   (United States)

Author keywords

CABG; Cell cycle; Intimal hyperplasia; PTEN; R point; Saphenous vein; Vein graft

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR 1A; CYCLIN DEPENDENT KINASE INHIBITOR 1B; CYCLIN E; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PTEN PROTEIN, HUMAN; RETINOBLASTOMA PROTEIN; SOMATOMEDIN C;

AGED; ARTICLE; CELL CYCLE; CELL PROLIFERATION; CORONARY ARTERY BYPASS GRAFT; CYTOLOGY; DRUG EFFECT; ENZYMOLOGY; GENE SILENCING; GENETIC TRANSFECTION; HUMAN; MAMMARY ARTERY; METABOLISM; MIDDLE AGED; PATHOLOGY; PHOSPHORYLATION; SAPHENOUS VEIN; SMOOTH MUSCLE FIBER;

AGED; CELL CYCLE; CELL PROLIFERATION; CORONARY ARTERY BYPASS; CYCLIN E; CYCLIN-DEPENDENT KINASE INHIBITOR P21; CYCLIN-DEPENDENT KINASE INHIBITOR P27; GENE SILENCING; HUMANS; INSULIN-LIKE GROWTH FACTOR I; MAMMARY ARTERIES; MIDDLE AGED; MYOCYTES, SMOOTH MUSCLE; PHOSPHORYLATION; PTEN PHOSPHOHYDROLASE; RETINOBLASTOMA PROTEIN; SAPHENOUS VEIN; TRANSFECTION;

EID: 63049138404     PISSN: 15821838     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1582-4934.2008.00384.x     Document Type: Article

References (25)

1. Johnson DG, Walker CL. Cyclins and cell cycle checkpoints. Annu Rev Pharmacol Toxicol. 1999 39 : 295 312.
2. Sherr CJ. Cancer cell cycles. Science. 1996 274 : 1672 77.
3. Morgan DO. Cyclin-dependent kinases: engines, clocks, and microprocessors. Annu Rev Cell Dev Biol. 1997 13 : 261 91.
4. Furnari FB, Huang HJ, Cavenee WK. The phosphoinositol phosphatase activity of PTEN mediates a serum-sensitive G1 growth arrest in glioma cells. Cancer Res. 1998 58 : 5002 8.
5. Li H, Lu S, Fong L. [Study on the status of methylation of Rb gene promoter in human esophageal cancer and effect of NMBzA on Rb gene promoter in monkey esophageal epithelium]. Zhonghua Zhong Liu Za Zhi. 1998 20 : 412 4.
6. Simpson MT, MacLaurin JG, Xu D, Ferguson KL, Vanderluit JL, Davoli MA, Roy S, Nicholson DW, Robertson GS, Park DS, Slack RS. Caspase 3 deficiency rescues peripheral nervous system defect in retinoblastoma nullizygous mice. J Neurosci. 2001 21 : 7089 98.
7. Pardee AB. A restriction point for control of normal animal cell proliferation. Proc Natl Acad Sci USA. 1974 71 : 1286 90.
8. Mitra AK, Jia G, Gangahar DM, Agrawal DK. Temporal inactivation causes proliferation of saphenous vein smooth muscle cells of human CABG conduits. J Cell Mol Med. 2008 12 : 1 13.
9. Abebe W, Cavallari N, Agrawal DK, Rowley J, Thorpe PE, Hunter WJ, Edwards JD. Functional and morphological assessment of rat aorta stored in University of Wisconsin and Eurocollins solutions. Transplantation. 1993 56 : 808 16.
10. Jia G, Mitra AK, Cheng G, Gangahar DM, Agrawal DK. Angiotensin II and IGF-1 regulate connexin43 expression via ERK and p38 signaling pathways in vascular smooth muscle cells of coronary artery bypass conduits. J Surg Res. 2007 142 : 137 42.
11. Jia G, Cheng G, Gangahar DM, Agrawal DK. Involvement of connexin 43 in angiotensin II-induced migration ad proliferation of saphenous vein smooth muscle cells via the MAPK-AP-1-signaling pathway. J Mol Cell Cardiol. 2008 44 : 882 90.
12. Graff P, Amellem O, Seim J, Stokke T, Pettersen EO. The role of p27 in controlling the oxygen-dependent checkpoint of mammalian cells in late G1. Anticancer Res. 2005 25 : 2259 67.
13. Martinsson HS, Zickert P, Starborg M, Larsson O, Zetterberg A. Changes in cell shape and anchorage in relation to the restriction point. J Cell Physiol. 2005 203 : 27 34.
14. Kozai T, Eto M, Yang Z, Shimokawa H, Luscher TF. Statins prevent pulsatile stretch-induced proliferation of human saphenous vein smooth muscle cells via inhibition of Rho/Rho-kinase pathway. Cardiovasc Res. 2005 68 : 475 82.
15. Dorafshar AH, Angle N, Bryer-Ash M, Huang D, Farooq MM, Gelabert HA, Freischlag JA. Vascular endothelial growth factor inhibits mitogen-induced vascular smooth muscle cell proliferation. J Surg Res. 2003 114 : 179 86.
16. Braun-Dullaeus RC, Mann MJ, Dzau VJ. Cell cycle progression: new therapeutic target for vascular proliferative disease. Circulation. 1998 98 : 82 9.
17. Miano JM, Vlasic N, Tota RR, Stemerman MB. Smooth muscle cell immediate-early gene and growth factor activation follows vascular injury. A putative in vivo mechanism for autocrine growth. Arterioscler Thromb. 1993 13 : 211 9.
18. Mann C, Boccara G, Fabre JM, Grevy V, Colson P. The detection of carbon dioxide embolism during laparoscopy in pigs: a comparison of transesophageal Doppler and end-tidal carbon dioxide monitoring. Acta Anaesthesiol Scand. 1997 41 : 281 6.
19. Yang ZY, Simari RD, Perkins ND, San H, Gordon D, Nabel GJ, Nabel EG. Role of the p21 cyclin-dependent kinase inhibitor in limiting intimal cell proliferation in response to arterial injury. Proc Natl Acad Sci USA. 1996 93 : 7905 10.
20. Hitomi M, Yang K, Guo Y, Fretthold J, Harwalkar J, Stacey DW. p27Kip1 and cyclin dependent kinase 2 regulate passage through the restriction point. Cell Cycle. 2006 5 : 2281 9.
21. Nallamshetty S, Crook M, Boehm M, Yoshimoto T, Olive M, Nabel EG. The cell cycle regulator p27Kip1 interacts with MCM7, a DNA replication licensing factor, to inhibit initiation of DNA replication. FEBS Lett. 2005 579 : 6529 36.
22. Dzau VJ, Braun-Dullaeus RC, Sedding DG. Vascular proliferation and atherosclerosis: new perspectives and therapeutic strategies. Nat Med. 2002 8 : 1249 56.
23. Grise MA, Massullo V, Jani S, Popma JJ, Russo RJ, Schatz RA, Guarneri EM, Steuterman S, Cloutier DA, Leon MB, Tripuraneni P, Teirstein PS. Five-year clinical follow-up after intracoronary radiation: results of a randomized clinical trial. Circulation. 2002 105 : 2737 40.
24. Vinals F, Pouyssegur J. Confluence of vascular endothelial cells induces cell cycle exit by inhibiting p42/p44 mitogen-activated protein kinase activity. Mol Cell Biol. 1999 19 : 2763 72.
25. Sakurai R, Bonneau HN, Honda Y, Fitzgerald PJ. Intravascular ultrasound findings in ENDEAVOR II and ENDEAVOR III. Am J Cardiol. 2007 100 : 71M 6M.